Aids activist group the Treatment Action Campaign (TAC) is ready to…move against...[Merck Sharp & Dohme, part of Merck] and Abbott...over their refusal to license multiple suppliers to produce and/or import generic versions of [AIDS drugs]..."Shortly our legal representative, the Aids Law Project, will file a complaint at the Competition Commission ... (seeking) an order compelling the two companies to grant multiple licenses on reasonable terms and conditions," the TAC said in a statement.